Keyword: RFM

The preliminary trial results of a novel radiopharmaceutical for PET imaging of inflammation developed at the University of Turku, Finland, have been published. The compound, which targets the vascular adhesion protein 1 (VAP-1) that regulates inflammatory cell traffic, is the first radiopharmaceutical that has been developed completely in Finland and has advanced to clinical trials. In the study that started with healthy volunteers, the radiopharmaceutical was found to be well tolerated and safe.

Consuming the combination of fish oil and probiotic food supplements modulate the composition of gut microbiota in overweight and obese pregnant women, reveals a new study conducted at the University of Turku, Finland. The same study shows that gut microbiota composition and function is not related to gestational diabetes.

A new study conducted in Turku reveals how symptoms indicating depression and anxiety are linked to brain function changes already in healthy individuals.

Glucocorticoids, which are widely used as treatment in intensive care, can nearly quadruple the death rate of patients suffering from acute respiratory distress syndrome. Researchers at the University of Turku, Finland, discovered the reason for the higher mortality. The findings are also important in the fight against COVID-19 disease.

Scientists from the Universities of Helsinki and Turku, Finland are part of the global consortium investigating the connection between the chemical senses and COVID-19. People with respiratory illnesses (including COVID-19) are urged to participate in survey on smell loss.

The Special Turku Coronary Risk Factor Intervention Project investigated the long-term effects of dietary counselling on cardiovascular health. The individuals, who had participated in the trial between ages 7 months and 20 years, were invited to a follow-up study at the age of 26. The results show that the intervention group who received dietary counselling had lower serum cholesterol level and better insulin sensitivity than those in the control group.

Researchers at the University of Turku, Turku University Central Hospital, and Western Cancer Center (FICAN West) have discovered a new RNA molecule, PRECSIT, which regulates the growth and invasion of squamous cell carcinoma of the skin. In the future, PRECSIT could potentially serve as a new marker for the detection of rapidly advancing or spreading squamous cell carcinoma and as a target for new therapies.

Infectious disease scientists identified strains of group A streptococcus that are less susceptible to commonly used antibiotics, a sign that the germ causing strep throat and flesh-eating disease may be moving closer to resistance to penicillin and other related antibiotics known as beta-lactams.

Study shows correlation between mothers’ self-reported pregnancy-related anxiety, and babies’ blood flow to brain areas responsible for emotional responses when listening to sad speech.